Bank of New York Mellon Corp decreased its stake in Elizabeth Arden Inc. (NASDAQ:RDEN) by 25.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 105,866 shares of the company’s stock after selling 35,808 shares during the period. Bank of New York Mellon Corp owned about 0.35% of Elizabeth Arden worth $1,457,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in RDEN. Kassirer Asset Management Corp bought a new stake in shares of Elizabeth Arden during the second quarter worth $3,612,000. Geode Capital Management LLC boosted its stake in shares of Elizabeth Arden by 2.9% in the first quarter. Geode Capital Management LLC now owns 172,530 shares of the company’s stock worth $1,413,000 after buying an additional 4,897 shares during the period. State Street Corp boosted its stake in shares of Elizabeth Arden by 3.8% in the first quarter. State Street Corp now owns 405,292 shares of the company’s stock worth $3,320,000 after buying an additional 14,867 shares during the period. Spark Investment Management LLC bought a new stake in shares of Elizabeth Arden during the first quarter worth $217,000. Finally, LMR Partners LLP bought a new stake in shares of Elizabeth Arden during the second quarter worth $2,894,000. 70.70% of the stock is owned by institutional investors and hedge funds.
Elizabeth Arden Inc. (NASDAQ:RDEN) remained flat at $13.98 on Tuesday. The firm’s 50-day moving average price is $13.93 and its 200 day moving average price is $10.50. Elizabeth Arden Inc. has a 1-year low of $5.02 and a 1-year high of $14.14.
Elizabeth Arden (NASDAQ:RDEN) last released its quarterly earnings data on Wednesday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.78) by $0.20. Elizabeth Arden had a negative net margin of 7.43% and a negative return on equity of 38.72%. The company earned $192.70 million during the quarter, compared to analyst estimates of $193.75 million. Equities research analysts anticipate that Elizabeth Arden Inc. will post ($0.49) EPS for the current year.
A number of equities research analysts recently weighed in on the stock. B. Riley reissued a “neutral” rating and issued a $14.00 price target on shares of Elizabeth Arden in a research report on Sunday, September 25th. Zacks Investment Research raised shares of Elizabeth Arden from a “hold” rating to a “buy” rating and set a $16.00 price target for the company in a research report on Tuesday, August 16th.
Elizabeth Arden Company Profile
Elizabeth Arden, Inc is a global beauty products company with a portfolio of fragrance, skin care and cosmetics brands. The Company’s product portfolio includes Elizabeth Arden Brand, such as the Elizabeth Arden skin care brands (Visible Difference, Ceramide, Prevage, Eight Hour Cream, Superstart and Elizabeth Arden Pro), Elizabeth Arden branded lipstick, foundation and other color cosmetics products and Elizabeth Arden fragrances (Red Door, 5th Avenue, Elizabeth Arden Green Tea and UNTOLD); designer fragrances, which include Juicy Couture, John Varvatos, and Wildfox Couture; Heritage Fragrances, such as Curve, Elizabeth Taylor, Britney Spears, Halston, Ed Hardy, Geoffrey Beene, Alfred Sung, Giorgio Beverly Hills, Lucky, PS Fine Cologne, White Shoulders, BCBGMAXAZRIA, Rocawear and Jennifer Aniston, and celebrity fragrances, which include the fragrance brands of Justin Bieber, Mariah Carey, Nicki Minaj and Taylor Swift.
Want to see what other hedge funds are holding RDEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elizabeth Arden Inc. (NASDAQ:RDEN).
Receive News & Ratings for Elizabeth Arden Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elizabeth Arden Inc. and related companies with MarketBeat.com's FREE daily email newsletter.